Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Produces acidic metabolites from both glucosamine and pyruvate.
Mikosza, A. S., La, T., de Boer, W. B., & Hampson, D. J. (2001). Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia. Journal of Clinical Microbiology, 39(1), 347–350.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, and pig intestine
DNA G+C(%): 24.6
|
Opt. T: 37-42℃
Mid T(℃): 32(neg)
High T(℃): 45(neg)
pH 4.2-5.9: 5.6(+)
pH 6.0-8.0: 8(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: S(10)
|
|
kanamycin: R(20)
neomycin: R(100)
spectinomycin: Res
streptomycin: R(50)
|
erythromycin: R(100)
spiramycin: R(50)
|
nalidixic-acid: R(200)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
vancomycin: Res
|
rifampicin: R(20)
|
chloramphenicol: S(5)
metronidazole: S(0.1)
|
lincomycin: S(1)
novobiocin: R(20)
colistin: Res
polymyxin_B: Res
|